Stockreport

Recursion and Exscientia Shareholders Approve the Proposed Combination

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF Salt Lake City USA, Oxford UK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) have each received overwhelming approval fr [Read more]